<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8">
    <title></title>
    <link rel="stylesheet" href="../../css/uswds.min.css">
    <link rel="stylesheet" href="../../css/style.css">
  </head>
  <body>

    <header>
        <h2 class="title">
            <a href="../../index.html">Code of Federal Regulations (alpha)</a>
        </h2>
    </header>

    <div class="usa-grid">
      <div class="usa-width-one-whole">
          <h3>
                                <a href="../../index.html">CFR</a><span>&nbsp/&nbsp</span>
                                <a href="../titles/title21.html">
                                    Title 21
                                </a><span>&nbsp/&nbsp</span>
                                <a href="../parts/21CFR814.html">Part 814
                                </a><span>&nbsp/&nbsp<span>
                                Sec. 814.100  Purpose and scope.
                            </h3>
                            <p class="depth1"><em>(a)</em> This subpart H implements sections 515A and 520(m) of the act.</p><p class="depth1"><em>(b)</em> The purpose of section 520(m) is, to the extent consistent with  the protection of the public health and safety and with ethical  standards, to encourage the discovery and use of devices intended to  benefit patients in the treatment or diagnosis of diseases or conditions  that affect or are manifested in fewer than 4,000 individuals in the  United States per year. This subpart provides procedures for obtaining:</p><p class="depth2"><em>(1)</em> HUD designation of a medical device; and</p><p class="depth2"><em>(2)</em> Marketing approval for the HUD notwithstanding the absence of  reasonable assurance of effectiveness that would otherwise be required  under sections 514 and 515 of the act.</p><p class="depth1"><em>(c)</em> Section 515A of the act is intended to ensure the submission of  readily available information concerning:</p><p class="depth2"><em>(1)</em> Any pediatric subpopulations (neonates, infants, children,  adolescents) that suffer from the disease or condition that the device  is intended to treat, diagnose, or cure; and</p><p class="depth2"><em>(2)</em> The number of affected pediatric patients.</p><p class="depth1"><em>(d)</em> Although a HUD may also have uses that differ from the  humanitarian use, applicants seeking approval of any non-HUD use shall  submit a PMA as required under Sec. 814.20, or a premarket notification  as required under part 807 of this chapter.</p><p class="depth1"><em>(e)</em> Obtaining marketing approval for a HUD involves two steps:</p><p class="depth2"><em>(1)</em> Obtaining designation of the device as a HUD from FDA's Office  of Orphan Products Development, and</p><p class="depth2"><em>(2)</em> Submitting an HDE to the Office of Device Evaluation (ODE),  Center for Devices and Radiological Health (CDRH), the Center for  Biologics Evaluation and Research (CBER), or the Center for Drug  Evaluation and Research (CDER), as applicable.</p><p class="depth1"><em>(f)</em> A person granted an exemption under section 520(m) of the act  shall submit periodic reports as described in Sec. 814.126(b).</p><p class="depth1"><em>(g)</em> FDA may suspend or withdraw approval of an HDE after providing  notice and an opportunity for an informal hearing.  [61 FR 33244, June 26, 1996, as amended at 63 FR 59220, Nov. 3, 1998; 73  FR 49942, Aug. 25, 2008; 79 FR 1740, Jan. 10, 2014]</p>
      </div>
    </div>

    <footer class="usa-footer usa-footer-slim" role="contentinfo">
    <div class="usa-grid usa-footer-return-to-top">
      <a href="#">Return to top</a>
    </div>
    <div class="usa-footer-primary-section">
      <div class="usa-grid-full">
        <h5>Built with ‚ù§ by <a href="https://18f.gsa.gov/">18F</a>.
          Code available <a href="https://github.com/18F/allregs">on Github.
        </a></h5>
        <h5>All regulations are from the 2015 Annual Edition.
          This is a technical demonstration not intended for serious use.</h5>
      </div>
    </div>
  </footer>
  </body>
</html>
